Gemcitabine and carboplatin induction chemotherapy followed by concurrent cisplatin and IMRT for locally advanced nasopharyngeal cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000509662

Enrollment

Registered

2005-09-26

Start date

2004-07-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Induction chemotherapy for 9 weeks followed by concurrent chemoradiation for 7 weeks.

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

WHO types 2 and 3 nasopharyngeal cancer; T3-4 and/or N1 > 3 cm, N2-3; no prior malignancies, no prior chemotherapy or radiation

Exclusion criteria

No exclusion criteria

Outcome results